Eli & Co Lilly, 10% Owner at Cerulean Pharma Inc. (CERU), bought 1,664,930 shares at $7.00 ($5.1M) on 2014-04-15, disclosed to the SEC on 2014-04-15.
Open-market purchase of $5.1M CERU by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 931,485 | $0 | 0.0% |
| 2 | $7.00 | 733,445 | $5.1M | 100.0% |
| Total | $3.08 avg | 1,664,930 | $5.1M | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |